The term muscular dystrophy encompasses a group of genetic diseases characterized by progressive muscle weakness and wasting. There are different types of muscular dystrophy depending on genetic ...

Sickle cell disease (SCD) is an inherited blood disorder marked by defective hemoglobin. It causes red blood cells (RBCs) to deform into a sickle shape, which results in premature death of the RBCs, ...

Follow Rare Disease Advisor's Sickle Cell Disease Junction for the latest news, resources, insights, and patient perspectives on the disease.

Chronic lymphocytic leukemia (CLL) is a hematologic malignancy characterized by the clonal expansion of abnormal B lymphocytes. 1 Despite significant advancements in targeted therapies like Bruton’s ...

Sheila Jacobs is the president of STJ Editorial Services. For more than 25 years, Sheila has been providing writing, fact-checking, and editorial services to numerous clients in the medical education, ...

Gastrointestinal (GI) symptoms are the second most frequent clinical manifestation of systemic mastocytosis (SM), after itching. They affect 15% to 85% of patients and have a significant impact on ...

Cold agglutinin disease (CAD) is a rare condition that is found in association with 15% of cases of autoimmune hemolytic anemia (AIHA). Hemolysis mediated by cold agglutinins results in mild to ...

The coexistence of hemolytic disease of the fetus and newborn (HDFN) due to anti-D and fetal and neonatal alloimmune thrombocytopenia (FNAIT) caused by anti-HPA-1a is exceedingly rare and had not been ...

The first case of sickle cell disease (SCD) in the United States was described in 1904 when Walter Clement Noel, a 20-year-old dental student from Grenada, sought care for anemia at Chicago ...

A patient with a 10-year history of relapsing chronic lymphocytic leukemia (CLL) developed amyotrophic lateral sclerosis (ALS) and a drug-related sarcoid-like reaction (SLR). This case report was ...

Patients who begin treatment for chronic inflammatory demyelinating polyneuropathy (CIDP) earlier may experience diminished progression of disability, according to findings recently published in the ...

New targeted treatments are being developed for patients with immunoglobulin G4-related disease (IgG4-RD) that have the potential to provide improved disease control with fewer adverse effects, thus ...